Rotavirus Infections and Vaccinations in
|
|
- Lizbeth Nicholson
- 5 years ago
- Views:
Transcription
1 Rotavirus Infections and Vaccinations in Children under Five in Lebanon Hassan Zaraket, RPh, PhD Assistant Professor Department of Microbiology and Immunology Member, Center for Infectious Diseases Research American University of Beirut Disclosures: No conflicts of interest
2 Learning points What is rotavirus disease? What are the signs and symptoms of rotavirus? How is rotavirus spread? 4 What are rotavirus prevention strategies? 5 What are the burden and prevalent rotavirus genotypes in Lebanon?
3 Rotavirus is the most common diarrheal pathogen Industrialized countries Less developed countries cases (%) Number of 100 Unknown 90 Bacteria Astrovirus 80 Calicivirus Adenovirus 70 Rotavirus cases (%) Number of Unknown Parasites Other bacteria Escherichia coli Adenovirus Calicivirus Adenovirus Rotavirus Kapikian AZ and Chanock RM. In: Fields Virology 3 rd ed, Philadelphia, PA: Lippincott Raven. 1996: WHO. Wkly Epidemiol Rec 2008;83:421 5
4 Who is most at risk in the population? Infants after the age of 3 months Low to no immunity Vulnerable to dehydration Baby > 3 months Immuno- compromised children Older children if they are immunocompromised Risk of disea ase Adults Elderly Population
5 Estimated global prevalence of rotavirus disease Parashar et al, Emerg Inf Dis 2003 Global burden
6 Rotavirus prevalence in Lebanon 3 years surveillance in children <5 year of age 866 (61%) 548 (39%) 35% 30% 25% 20% 15% 10% 5% Percentage distribution of RV GE cases by age group (n= 548) 61 (11%) 110 (20%) 83% 107 (20%) 175 (32%) 58 (11%) 19 (3%) 18 (3%) RVGE Non RVGE 0% 0-4m 4-8m 8-12m 1-2yr 2-3yrs 3-4yrs 4-5yrs Source: Dr. Ghassan Dbaibo, AUBMC
7 Distribution of rotavirus gastroenteritis cases per hospital 60% 119 (56%) 50% 40% 30% 92 (44%) 32 (37%) 53 (34%) 191 (34%) 61 (32%) 20% 10% 0% Source: Dr. Ghassan Dbaibo, AUBMC Nabatieh Hammoud RHUH AUB NINI Makassed
8 Clinical features of rotavirus infection Day: Incubation Symptomatic period 2 period 1 bd i l i 2 Diarrhea 3 Abdominal pain 2 Vomiting 3 Fever 39 C 3 Headache 2 Nausea 2 Malaise 2 1. Raebel MA and Ou BS. Pharmacotherapy 1999;19: Anderson EJ and Weber SG. Lancet Infect Dis 2004;4: Staat MA, et al. Pediatr Infect Dis J 2002;21:221 7
9 Severe rotavirus gastroenteritis RVGE can be severe enough to require hospitalization ti in young infants and children 1 RV infection is unpredictable with symptoms that include: 2 Severe diarrhea Vomiting Fever Dehydration Electrolyte disturbances Shock 1. Flewett T, et al. J Clin Pathol 1976;27: Staat M, et al. PAS May Baltimore, MD and pers comm
10 How does rotavirus spread? Rotavirus infection is highly hl contagious Fecal matter from infected infants contains as many as particles per gram Rotavirus spread by fecal oral oralrouteroute The primary mode of transmission of rotavirus is the passage of the virus in stool to the mouth of another child 1. Hrdy. Rev Infect Dis 1987;9:461 9
11 Prevention of rotavirus gastroenteritis: Vaccination
12 The clinical basis for rotavirus vaccination Two natural infections provide 100% protection against subsequent moderate/severe disease Nearly 50% of children suffered a third infection, but all were either asymptomatic or were associated with only mild illnesses Probability of rotavirus in nfection st infection 2nd infection 3rd infection 4th infection 5th infection Moderate severe Mild asymptomatic Asymptomatic or mild illness Age (months) Adapted from Velázquez et al. N Engl J Med 1996;335:1022 8
13 Goal of rotavirus vaccination To mimic protection conferred by natural rotavirus infections Two natural rotavirus infections provide 100% protection against a subsequent moderate/severe infection Two vaccine infections could po provide ~50% protection potecto against infection and ~100% protection against moderate to severe disease rotavirus infe ection Probability of Two vaccine doses 1 st natural infection becomes the third encounter with a rotavirus 4th infection 5th infection Moderate severe Mild asymptomatic Age (months) Adapted from Velázquez et al. N Engl J Med 1996;335:1022 8
14 Rotavirus structure Virus particles possessa a triple layered layered icosahedral protein capsid composed ofan outer layer, an intermediate layer and an inner core layer 1 Outer capsid contains VP4 and VP7 antigens which induce neutralizing antibodies directed against rotavirus 1 Inner capsid contains VP6 antigen, the major RV group antigen (comprising >80% protein mass of particle) 2 Genome consists of 11 segments of double stranded RNA 1,2 MIDDLE CAPSID VP6 Groups (7) A, B, C, D, E, F, G Family: Reoviridae OUTER CAPSID VP7, VP4 G and P Types VP7 VP4 G P 1. Estes M, et al. In: Fields Virology (Knipe DM, et al., eds). 2001; Estes MK, et al. J Virol 1987;61:
15 Common rotavirus genotypes Common G and P combinations: G1, G3, and G4 with P1A[8] 1,2 G2 with P1B[4] 1,2 G9 with P[8] or P[6] 1 1. Santos N and Hoshino Y. Rev Med Virol 2005;15: Gentsch JR, et al. J Infect Dis 1996;17(suppl 1):30 6
16 Prevalence of rotavirus genotypes in Lebanon Source: Dr. Ghassan Dbaibo, AUBMC 164 (38.2%) 95 (22%) 79 (18.4%) 72 (17%) 7 (1.6%) 5 (1.2%) 2 (0.5%) 2 (0.5%) 1 (0.2%) 1 (0.2%) 1 (0.2%) 0 G1P8 G9P8 G4P8 G2P4 G12P6 G9P6 G9P4 G3P6 G3P9 G2P8 G1P6 4-5yrs yrs yrs yr m m m
17 Seasonal variation of RVGE cases by yy year 2011, 2012 and G9P6 G1P6 G3P6 G9P4 G3P9 G2P8 G9P6 G12P6 G9P8 G2P4 G4P8 G1P8 Jan Feb Mar Apr May June July Aug Sep Oct Nov Dec Jan Feb Mar Apr May June July Aug Sep Oct Nov Dec Jan Feb Mar Apr May June Source: Dr. Ghassan Dbaibo, AUBMC
18 Rotavirus FDA approved vaccines Bovine human reassortant t(rv5) G1P7[5], G2P[5], G3P[5], G4P[5], [ G6P[8] [ ] (5 relevant antigens) Covers G1, G2, G3, and G4 Three oral doses (2, 4, and 6 mos) WHO. Weekly Epi Rep 2007; 32:
19 Rotavirus FDA approved vaccines Bovine human reassortant t(rv5) G1P7[5], G2P[5], G3P[5], G4P[5], [ G6P[8] [ ] (5 relevant antigens) Covers G1, G2, G3, and G4 Three oral doses (2,4, and 6 mos) Human attenuated (RV1) G1P[8] (2 relevant antigens) Covers G1 and non G1 types (G3, G4, and G9) Two oral doses (2 and 4 mos) WHO recommended in 2009 that they are included in national immunization programs WHO. Weekly Epi Rep 2007; 32:
20 Vaccines demonstrate high efficacy against RVGE Through h the first rotavirus season after vaccination: i RV1 1,2 RV5 2,3 96% efficacy against severe gastroenteritis 98% efficacy 87% efficacy against any severity of gastroenteritis 74% efficacy Up to 2 years after vaccination: in the combined incidence of hospitalizations/ed visits for gastroenteritis ~96% reduction ~96% reduction 1. Ruiz Palacios N Engl J Med 2006;354:11 22, Vesikari T, Matson DO, Dennehy P, et al. N Engl J Med. 2006;354:23 33
21 Vaccines demonstrate high efficacy against RVGE Through h the first rotavirus season after vaccination: i RV1 1,2 RV5 2,3 96% efficacy against severe gastroenteritis 98% efficacy 87% efficacy against any severity of gastroenteritis Up to 2 years after vaccination: in the combined incidence of hospitalizations/ed visits for gastroenteritis 74% efficacy ~96% reduction ~96% reduction The most common adverse events: (occurred in vaccinated and placebo) RV1: fussiness, irritability, i cough, runny nose, fever, loss of appetite, vomiting, ii diarrhea RV5: diarrhea, vomiting, irritability, otitis media, nasopharyngitis, and bronchospasm 1. Ruiz Palacios N Engl J Med 2006;354:11 22, Vesikari T, Matson DO, Dennehy P, et al. N Engl J Med. 2006;354:23 33
22 Rotavirus vaccine guidelines 2 (RV1) or 3 (RV5) oral doses beginning i at 2 months of age may be started as early as 6 weeks of age For both rotavirus vaccines maximum age for first dose is 14 weeks 6 days minimum interval between doses is 4 weeks maximum age for any dose is 8 months 0 days
23 Rotavirus vaccine guidelines 2 (RV1) or 3 (RV5) oral doses beginning at 2 months of age may be started as early as 6 weeks of age For both rotavirus vaccines maximum age for first dose is 14 weeks 6 days minimum interval between doses is 4 weeks maximum age for any dose is 8 months 0 days Rotavirus Vaccine Contraindications: Severe allergic reaction to a vaccine component (including latex) or following a prior dose of vaccine latex rubber is contained in the RV1 oral applicator History of intussusception Severe combined immunodeficiency (SCID)
24 Do these vaccines work?
25 Post licensure vaccine effectiveness and impact In the USA, RV5 used predominantly Equivalent reductions in ED visits and hospitalizations due to rotavirus were observed The National Respiratory and Enteric Viruses Surveillance System (NREVSS): manual/chpt13 rotavirus.html
26 How are we doing in Lebanon?
27 Rotavirus vaccination rate among all patients admitted with GE in Lebanon 1158 (82%) 27 (11%) 9 (3%) (RV1) Vaccine (RV5) Vaccine Unkown type 254 (17%) 219 (86%) Non Vaccinated Cohort% Vaccinated Cohort% 2 (1%) Unknown Vacc.% Source: Dr. Ghassan Dbaibo, AUBMC
28 Source: Dr. Ghassan Dbaibo, AUBMC Vaccination rates per center among patients admitted with GE
29 Rotavirus infections among vaccinated & non vaccinated patients The rate of RV in vaccinated (any dose) subjects= 50/254 (20%) The rate of RV in non vaccinated subjects= 379/1158 (33%) 475 (87%) 73 (13%) Vaccinated patients with Rota Positive GE Non Vaccinated patients with Rota Positive GE
30 Vaccinated Subjects One dose (RV1) Vac n= 54 (25%) n= 219 (86%) Two doses n=165 (75%) Vaccinated Subjects n= 254 (18%) (RV5) Vac n= 27 (11%) Unknown n= 9 (4%) One dose n=8 (30%) Two doses n=3 (11%) Three doses n=16 (59%)
31 Conclusions Rotavirus accounts for a significant burden of disease in hospitalized children under 5 years of age in Lebanon The majority of affected children are under 2 years of age Four major genotypes account for the majority of infected children Winter peak predominates Significant ifi breakthrough hinfection i in vaccinated children Rotavirus vaccines are highly effective
32 Acknowledgements American University of Beirut Medical Center (CIDR team) Hammoud Hospital (Dr. Ghassan Baasiri) Hotel Dieu de France (Dr. Bernard Gerbaka) Makassed General Hospital (Dr. Mariam Rajab) Nabatieh Hospital (Dr. Bassam Ghanem) Nini Hospital (Dr. Adlette Inati) Rafik Hariri University Hospital (Dr. Hassan Fakhoury) MSD for funding
33
34 Mutations in antigens of vaccine breakthrough g g strains
35 Vaccine Breakthrough The rate of RV in vaccinated (any dose) subjects= 50/254 (20%) The rate of RV in non-vaccinated subjects= 379/1158 (33%) (RV1) Vaccine breakthrough: 40/219 (18%) (RV5) Vaccine breakthrough: 7/27 (26%) Unknown vaccination breakthrough: 3 subjects
36 Breakthrough Rotavirus Gastroenteritis Among Vaccinated & Non-Vaccinated Patients By PCRs All PCRs 548 Positive PCR 429 Negative PCR among vacc (11.6%)
37 (RV1) Vaccine Breakthrough 35% 30% 33% 30% 25% 20% 15% 10% 20% 15% 5% 0% 3% G2P[4] G1P[8] G9P[8] G4P[8] G2P[8] Percentage genotype distribution of (RV1) Vaccine breakthrough subjects (n= 40)
38 Genotypes among RV1 vaccine breakthrough [Total no: 40 ; 1 unknown date] 25% 20% 15% 10% 8 20% 4 10% 4 10% 9 23% 6 15% 7 18% 1st dose 2nd dose 5% 1 3% 1 3% 0% G1P[8] G2P[4] G2P[8] G4P[8] G9P[8] P t t di t ib ti frv1 i Percentage genotype distribution of RV1 vaccine breakthrough subjects per # of doses
39 Vaccine Breakthrough Ratio Among All Vaccinated Patients By PCR; Comparing The Two Vaccine Types (100%) (18%) (RV1) Vaccine Vaccinated Patients 27 (100%) 7 (26%) (RV5) Vaccine Vaccine Breakthrough
40 (RV5) Vaccine Breakthrough 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% 43% 29% 14% 14% G4P[8] G1P[8] G2P[4] G9P[4] Percentage genotype distribution of (RV5) Vaccine breakthrough subjects (n= 7)
41 (RV5) Vaccine Breakthrough 35% 30% 25% 2 29% 2 29% 20% st dose 15% 14% 14% 14% 2nd dose 3rd dose 10% 5% 0% G1P[8] G2P[4] G4P[8] G9P[8] Percentage genotype distribution of (RV5) Vaccine breakthrough subjects per no. of doses
42 Reassorted Rotavirus Vaccine, RV5 Demonstrated Substantial Efficacy Against G1, G2, G3, org4 RVGE a in REST b Through the first rotavirus season after vaccination: 98% efficacy against severe RGE (N=5,673) 74% efficacy against any severity of RGE (N=5,673) Up to 2 years after vaccination: in the combined incidence of ~95% reduction hospitalizations/ed c visits for RGE (N=68,038) In clinical trials, the most common adverse events included diarrhea, vomiting, irritability, otitis media, nasopharyngitis, and bronchospasm. Vesikari T, Matson DO, Dennehy P, et al. N Engl J Med. 2006;354: a RVGE=rotavirus gastroenteritis; b REST=Rotavirus Efficacy and Safety Trial; c ED=emergency department.
43 In the USA, RV5 used predominantly: Diarrhea-Associated Health Care Utilization among Children under 5 Years of Age According to Month and Setting, January 2001 June Hospitalization Emergency Department Visit Outpatient Visit Cortes JE et al. N Engl J Med 2011;365:
44 Diarrhoea and rotavirus related admissions among children aged less than 5 years at seven hospitals in El Salvadorde Palma, et al 2010
45 Type of Rotavirus vaccine received 27 (11%) 9 (3%) (RV1) Vaccine (RV5)V Vaccine Unkown type 219 (86%)
46 Vaccination Rates per Center Among Patients Admitted with GE 70% 60% 50% 40% 30% 20% 10% 0% 3 (60%) 61 (39%) 57 (27%) 52 (25%) (11%) (10%) 4 (5%) HD AUB Hammoud NGUH Nini Makassed RHUH
9/11/2018. Rotavirus. Rotavirus. Rotavirus. First identified as a cause of diarrhea in 1973
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Rotavirus September 2018 Photographs and images included in this presentation are licensed solely for
More informationPrevention of Rotavirus Infections. Dr. ANCA DRAGANESCU INBI Matei Bals Bucuresti
Prevention of Rotavirus Infections Dr. ANCA DRAGANESCU INBI Matei Bals Bucuresti Worldwide, Rotavirus Accounted for ~215,000 Childhood Deaths Annually 1 (2000-2013) In children less than 5 years of age:
More informationVIRAL AGENTS CAUSING GASTROENTERITIS
VIRAL AGENTS CAUSING GASTROENTERITIS VIRAL AGENTS CAUSING GASTROENTERITIS Pathogens discussed in our lectures 1. Rotavirus 2. Enteric adenoviruses 3. Caliciviruses 4. Astroviruses 5. Toroviruses Viruses
More informationROTAVIRUS VACCINES. Virology
ROTAVIRUS VACCINES Virology Rotavirus is a triple-layers viral particle belonging to the Reoviridae family. It contains 11 segments of double-stranded RNA, of which 6 are structural and 5 are non-structural
More informationViral Agents of Paediatric Gastroenteritis
Viral Agents of Paediatric Gastroenteritis Dr Carl Kirkwood -------------------- Enteric Virus Research Group Murdoch Childrens Research Institute Royal Children s Hospital Victoria. WHO Collaborating
More informationIASR Back Number Vol.35. The Topic of This Month Vol.35 No.3 (No.409) Rotavirus, , Japan. (IASR 35: 63-64, March 2014) Phoca PDF
The Topic of This Month Vol.35 No.3 (No.409) Rotavirus, 2010-2013, Japan (IASR 35: 63-64, March 2014) Rotavirus belongs to the family Reoviridae, whose genome consists of 11 segments of double-stranded
More informationHaemophilus influenzae type B and Hib Vaccine Chapter 9
Haemophilus influenzae type B and Hib Vaccine Chapter 9 Haemophilus influenzae Aerobic gram-negative bacteria Polysaccharide capsule Six different serotypes (a-f) of polysaccharide capsule 95% of invasive
More informationGastroenteritis and viral infections
Gastroenteritis and viral infections A Large number of viruses are found in the human gut; these include some that are associated with gastroenteritis Rotaviruses Adenoviruses 40/41 Caliciviruses Norwalk-like
More informationVIRAL GASTROENTERITIS
VIRAL GASTROENTERITIS (GI & N Block, Microbiology : 2016) By: Dr.Malak M. El-Hazmi OBJECTIVES Ø VIRAL GASTROENTERITIS (VGE) n Etiology of VGE n Epidemiology n Clinical Features n Lab diagnosis n Treatment
More informationFecal shedding of rotavirus vaccine in premature babies in the neonatal unit
Fecal shedding of rotavirus vaccine in premature babies in the neonatal unit Dr. Manish Sadarangani Director, Vaccine Evaluation Center, BC Children s Hospital Research Institute Assistant Professor, Division
More informationViruse associated gastrointestinal infection
Viruse associated gastrointestinal infection Dr. Hala Al Daghistani Rotaviruses Rotaviruses are a major cause of diarrheal illness in human (infants), and young animals, including calves and piglets. Infections
More informationU.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Foodborne Pathogenic Microorganisms and Natural Toxins Handbook.
U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Foodborne Pathogenic Microorganisms and Natural Toxins Handbook Rotavirus 1. Name of the Organism: Rotavirus Rotaviruses are classified
More informationRotavirus serotype surveillance: Results and experiences in Tanzania. Adolfine Hokororo. KPA Vaccinology Symposium- 29 th April
Rotavirus serotype surveillance: Results and experiences in Tanzania Adolfine Hokororo KPA Vaccinology Symposium- 29 th April 2016 1 outline 1. Introduction-burden of RVGE 2. goals of RVGE sentinel surveillance
More informationTraining in Infectious Diseases Modeling. A reflection on vaccination as a disease control measure
Training in Infectious Diseases Modeling A reflection on vaccination as a disease control measure -Example of Rotavirus disease- Participant s Guide Adapted by Nathalie Elomeiri; Camelia Savulescu; Fernando
More informationROTAVIRUS VACCINES FOR AUSTRALIAN CHILDREN: INFORMATION FOR GPS AND IMMUNISATION PROVIDERS
ROTAVIRUS VACCINES FOR AUSTRALIAN CHILDREN: INFORMATION FOR GPS AND IMMUNISATION PROVIDERS Summary Rotavirus is the most common cause of severe gastroenteritis in infants and young children, accounting
More informationRotarix : Global Efficacy against Severe RV GE due to G1 and non-g1 (G2, G3, G4, G9) RV Types
Rotarix : Global Efficacy against Severe RV GE due to G1 and non-g1 (G2, G3, G4, G9) RV Types 8 th International Rotavirus Symposium Istanbul, 3 rd June 2008 Dr. Norman Begg, Vice President, Clinical Development
More informationExperience of Pentavalent Human-bovine Reassortant Rotavirus Vaccine Among Healthy Infants in Taiwan
ORIGINAL ARTICLE Experience of Pentavalent Human-bovine Reassortant Rotavirus Vaccine Among Healthy Infants in Taiwan Chien-Chih Chang, 1 Mei-Hwei Chang, 1 * Tzou-Yen Lin, 2 Hong-Chang Lee, 3 Wu-Shiun
More informationVIRAL GASTRO-ENTERITIS
VIRAL GASTRO-ENTERITIS Dr Esam Ibraheem Azhar (BSc, MSc, Ph.D Molecular Medical Virology) Asst. Prof. Medical Laboratory Technology Department ١ Gastroenteritis Introduction (1) Paediatric diarrhoea remains
More informationGSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationGlobal Impact of Enteric Disease Deaths in young children
1 Global Impact of Enteric Disease Deaths in young children 2 Average of 2.2 million deaths per year worldwide Typhoid 600 000 Cholera 120 000 ETEC 380 000 Rotavirus 450 000 Shigella 670 000 WHO, 2000
More informationTHIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE
THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE The following content is provided for informational purposes only. PREVENTION AND CONTROL OF INFLUENZA Lisa McHugh, MPH Influenza can be a serious
More informationInfluenza 2009: Not Yet The Perfect Storm
Influenza 2009: Not Yet The Perfect Storm What s needed for a pandemic strain? Novel virus (little to no immunity) Capable of causing disease in humans Highly pathogenic / virulent Capable of sustained
More informationThe following are well-established causal agents of viral gastroenteritis in humans: f. HSV, CMV in immunocompromised patients (not discussed here)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah VIRAL GASTROENTERITIS AGENTS The following are well-established causal agents of viral gastroenteritis in humans: a. Rotavirus b. Enteric adenoviruses
More informationNorthwestern Health Unit
Northwestern Health Unit www.nwhu.on.ca 210 First Street North Kenora Ontario P9N 2K4 1-800-830-5978 July 26, 2018 Re: Ontario Rotavirus Immunization Program - Transitioning to RotaTeq (Rot-5) pentavalent
More informationGlaxoSmithKline Biologicals Rotarix WHO PACKAGE INSERT. Rotarix TM 1 WHO Package insert
GlaxoSmithKline Biologicals Rotarix WHO PACKAGE INSERT Rotarix TM 1 WHO Package insert GlaxoSmithKline Biologicals Rotarix Method of administration Rotarix is for oral use only. ROTARIX SHOULD UNDER NO
More informationDoes Rota Vaccine Reduce Attacks of Acute Gastroenteritis among Children Under 15 Months of Age?
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 1178-1184 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.142
More informationPrevalence and Molecular characterization of the Human Rotavirus strains detected in children suffering from acute gastroenteritis at Wardha
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Volume 2, Issue 2-2016 Original Research Article http://s-o-i.org/1.15/ijcrms-2016-2-2-6 Prevalence and Molecular
More informationAn update on the laboratory detection and epidemiology of astrovirus, adenovirus, sapovirus, and enterovirus in gastrointestinal disease
An update on the laboratory detection and epidemiology of astrovirus, adenovirus, sapovirus, and enterovirus in gastrointestinal disease Christopher McIver, Principal Hospital Scientist, Microbiology Department
More informationCore 3: Epidemiology and Risk Analysis
Core 3: Epidemiology and Risk Analysis Aron J. Hall, DVM, MSPH, DACVPM CDC Viral Gastroenteritis Team NoroCORE Full Collaborative Meeting, Atlanta, GA November 7, 2012 Core 3: Purpose and Personnel * Purpose:
More informationLongitudinal Studies of Neutralizing Antibody Responses to Rotavirus in Stools and Sera of Children following Severe Rotavirus Gastroenteritis
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Nov. 1998, p. 897 901 Vol. 5, No. 6 1071-412X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Longitudinal Studies of
More informationLessons from Rotavirus Vaccine Implementation in the U.S.
Lessons from Rotavirus Vaccine Implementation in the U.S. Jeff Duchin, MD Chief, Communicable Disease Epidemiology & Immunization Section Public Health - Seattle & King County Professor in Medicine, Division
More informationVaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA
TM Vaccines against Rotavirus & Norovirus Umesh D. Parashar CDC, Atlanta, GA 1 Rotavirus is the Leading Cause Of Severe Diarrhea in Children
More informationTitle page. Adults COM R
Influenza and Older Title page Adults COM 10927-2R Overview of Today s Presentation Important Flu Information Everyone Needs to Know Risks for Older Adults The flu is a contagious illness that can be severe
More informationNoroviruses. Duncan Steele Bill & Melinda Gates Foundation. Acknowledgements: Ben Lopman and Umesh Parashar, CDC Megan Carey and Julia Bosch, BMGF
Noroviruses Duncan Steele Bill & Melinda Gates Foundation Acknowledgements: Ben Lopman and Umesh Parashar, CDC Megan Carey and Julia Bosch, BMGF 1 Global norovirus burden Globally, norovirus is associated
More informationInfluenza Season and EV-D68 Update. Johnathan Ledbetter, MPH
2014-2015 Influenza Season and EV-D68 Update Johnathan Ledbetter, MPH 2014-2015 Influenza Season Influenza Reporting Individual cases are not reportable in the state of Texas Situations where influenza
More informationA prospective hospital-based surveillance of Rotaviral Disease in children at the Port Moresby General Hospital, Papua New Guinea. Dr.
A prospective hospital-based surveillance of Rotaviral Disease in children at the Port Moresby General Hospital, Papua New Guinea. Dr. Fiona Kupe Principle Investigator: Dr. Fiona Kupe 1 Co-Investigators:
More informationAcute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).
Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1
More informationThe reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.
NEW ZEALAND DATA SHEET Name of Medicine RotaTeq rotavirus vaccine, live, oral, pentavalent Single dose 2 ml unit dosing tube Presentation RotaTeq is available as a single, pre-filled 2 ml unit dose in
More informationGastroenteritis Viruses Prof. Mary K. Estes
Gastroenteritis Viruses Mary K. Estes, Ph.D. Professor of Molecular Virology and Microbiology and Medicine-GI, BCM Director, Texas Medical Center DDC 1 Outline Gastrointestinal viruses Rotaviruses Noroviruses
More informationMcHenry County Norovirus Outbreaks November McHenry County Department of Health November 29,2010
McHenry County Norovirus Outbreaks November 2010 McHenry County Department of Health November 29,2010 What is Norovirus The most common cause of gastrointestinal illness resulting from an inflammation
More informationAstrovirus associated gastroenteritis in a children's ward
J. clin. Path., 1977, 30, 948-952 Astrovirus associated gastroenteritis in a children's ward J. B. KURTZ, T. W. LEE, AND D. PICKERING From the Virology and Public Health Laboratory, Churchill Hospital,
More informationFoodborne Disease in the Region of Peel
Foodborne Disease in the Region of Peel HIGHLIGHTS The incidence of selected foodborne diseases was generally higher in Peel than in Ontario between 1993 and 22. A higher incidence was observed in Peel
More informationCorrelates of efficacy for human rotavirus vaccines Value of anti-rotavirus immunoglobulin A antibody concentrations
Correlates of efficacy for human rotavirus vaccines Value of anti-rotavirus immunoglobulin A antibody concentrations Brigitte Cheuvart, Kathleen M. Neuzil, Duncan Steele, Nigel Cunliffe, Shabir A. Madhi,
More informationMID 33. Gastrointestinal Viruses. Gastrointestinal Viruses: Rotavirus and the Enteroviruses. Childhood diarrheal disease
Gastrointestinal Viruses Gastrointestinal Viruses: Rotavirus and the Enteroviruses Viral diarrheal illness o tremendous cause of morbidity/mortality worldwide o rotavirus, calicivirus (norovirus), astrovirus,
More informationUS Rotavirus Vaccination Program
US Rotavirus Vaccination Program 1 Rotavirus Vaccines in US Feb 2006 Feb 2006 April 2008 June 2008 RotaTeq licensed by FDA RotaTeq recommended by ACIP Rotarix licensed by FDA ACIP to consider Rotarix 2
More informationGSK Medicine: Rotarix (HRV): GlaxoSmithKline Biologicals live attenuated human rotavirus vaccine Study No.: (EPI-ROTA ) Title:
GSK Medicine: Rotarix (HRV): GlaxoSmithKline Biologicals live attenuated human rotavirus Study No.: 111426 (EPI-ROTA-111426) Title: Case-control study to evaluate the effectiveness of GlaxoSmithKline (GSK)
More information10/6/2014. INFLUENZA: Why Should We Take The Vaccine? OUTLINE INFLUNZA VIRUS INFLUENZA VIRUS INFLUENZA VIRUS
INFLUENZA: Why Should We Take The Vaccine? Baptist Hospital Baptist Children s Hospital Doctors Hospital J. Milton Gaviria, MD, FACP October 17, 2014 Homestead Hospital Mariners Hospital Baptist Cardiac
More informationROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT
ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT RotaTeq Solution for Oral Administration THERAPEUTIC CLASS ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT hereafter referred to as PENTAVALENT ROTAVIRUS VACCINE (RotaTeq),
More informationRotavirus. Factsheet for parents. Immunisation for babies up to a year old
Rotavirus Factsheet for parents This factsheet describes the rotavirus infection and the vaccine that protects against it. It also provides the background to the development and introduction of the vaccination
More informationSeasonality of influenza activity in Hong Kong and its association with meteorological variations
Seasonality of influenza activity in Hong Kong and its association with meteorological variations Prof. Paul Chan Department of Microbiology The Chinese University of Hong Kong Mr. HY Mok Senior Scientific
More informationLECTURE: Viral Gastroenteritis
LECTURE: Viral Gastroenteritis Editing File Important Doctor s notes Extra explanation Only F or only M "ال حول وال قوة إال باهلل العلي العظيم" وتقال هذه الجملة إذا داهم اإلنسان أمر عظيم ال يستطيعه أو
More informationValue of post-licensure data to assess public health value Example of rotavirus vaccines
Value of post-licensure data to assess public health value Example of rotavirus vaccines TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines
More informationA rotavirus immunisation programme was introduced into the routine childhood immunisation programme from 1 July 2013 for infants aged 2 and 3 months.
A rotavirus immunisation programme was introduced into the routine childhood immunisation programme from 1 July 2013 for infants aged 2 and 3 months. Rotavirus is a very common and potentially serious
More informationMeasles: United States, January 1 through June 10, 2011
Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA
More informationInfluenza. By Allison Canestaro-Garcia. Disease Etiology:
Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four
More informationUpdate on Pentavalent Human-Bovine Rotavirus Vaccine. Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014
Update on Pentavalent Human-Bovine Rotavirus Vaccine Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014 Outline Characteristics of RotaTeq and its worldwide use Recent data evaluating
More informationEffectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases
TECHNICAL DOCUMENT Effectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases www.ecdc.europa.eu ECDC TECHNICAL DOCUMENT Effectiveness
More informationThe Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond
The Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond Max Ciarlet, PhD Vaccines Clinical Research Department Merck Research Laboratories North Wales, Pennsylvania, United
More informationLEC 2, Medical biology, Theory, prepared by Dr. AYAT ALI
General Characteristics, Structure and Taxonomy of Viruses Viruses A virus is non-cellular organisms made up of genetic material and protein that can invade living cells. They are considered both a living
More information(and what you can do about them)
(and what you can do about them) What s an outbreak? In general, more cases than expected (baseline) More cases clustered in a specific unit or facility than you d expect at a particular time of year Some
More informationEPIDEMIOLOGY OF CRYPTOSPORIDIOSIS IN IRELAND
EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results Incidence 8 Age distribution 9 Seasonality
More informationPediatric News. Rotavirus in the Modern Age. Prevention as a Strategy for Reducing Morbidity, Mortality, and Economic Burden of the Disease
A SUPPLEMENT TO Pediatric News Rotavirus in the Modern Age Prevention as a Strategy for Reducing Morbidity, Mortality, and Economic Burden of the Disease TOPIC HIGHLIGHTS: BURDEN OF DISEASE UNDERSTANDING
More informationPandemic H1N1 2009: The Public Health Perspective. Massachusetts Department of Public Health November, 2009
Pandemic H1N1 2009: The Public Health Perspective Massachusetts Department of Public Health November, 2009 Training Objectives Describe and distinguish between seasonal and pandemic influenza. Provide
More informationConsiderations for Introduction of a Rotavirus Vaccine in Oman: Rotavirus Disease and Economic Burden
SUPPLEMENT ARTICLE Considerations for Introduction of a Rotavirus Vaccine in Oman: Rotavirus Disease and Economic Burden S. A. Al Awaidy, 1 S. Bawikar, 1 S. Al Busaidy, 2 S. Baqiani, 2 I. Al Abedani, 1
More informationInfluenza. Gwen Clutario, Terry Chhour, Karen Lee
Influenza Gwen Clutario, Terry Chhour, Karen Lee Overview Commonly referred to as the flu Defined as a highly contagious viral infection where it starts at the upper respiratory tract and attacks the nose,
More informationESCMID Online Lecture Library
Vaccines against norovirus state of the art, trials in children and adults Hugues Bogaerts MD global vaccine consultant at H+B 3rd ESCMID Conference on Vaccines 1 Between Jan and 22 Dec 2014, 689 outbreaks
More informationOverview of the Influenza Virus
Overview of the Influenza Virus Victor C. Huber, Ph.D. September 24, 2015 victor.huber@usd.edu General Features of Influenza Virus Infections Clinical Features of Influenza Sudden onset of symptoms Incubation
More informationRotavirus Factsheet What you need to know about Rotavirus
THE REPUBLIC OF UGANDA MINISTRY OF HEALTH Introduction Rotavirus Factsheet What you need to know about Rotavirus Rotavirus infection is the leading cause of diarrhoea in children under 5 years of age worldwide.
More informationph1n1 H3N2: A Novel Influenza Virus Reassortment
ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain
More informationNew and Underused Vaccines, Rotavirus
New and Underused Vaccines, Rotavirus George Armah Noguchi Memorial Institute for Medical research University of Ghana 10th Annual African Vaccinology Course (VACFA) Cape town, South Africa 10 th to 14
More informationMalik Sallam. Ola AL-juneidi. Ammar Ramadan. 0 P a g e
1 Malik Sallam Ola AL-juneidi Ammar Ramadan 0 P a g e Today's lecture will be about viral upper respiratory tract infections. Those include: common cold, sinusitis, otitis, etc. Infections in the upper
More informationArboviruses in Florida. Carina Blackmore, DVM, PhD Florida Department of Health Bureau of Environmental Public Health Medicine
Arboviruses in Florida Carina Blackmore, DVM, PhD Florida Department of Health Bureau of Environmental Public Health Medicine Arboviruses in Florida Flaviviruses West Nile St. Louis Encephalitis Alphaviruses
More informationINFLUENZA WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST THE FLU?
INFLUENZA WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST THE FLU? GET INFORMED! GET VACCINATED! GET PROTECTED! FLU VACCINE WHAT IS INFLUENZA? Seasonal influenza
More informationThe reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.
PRODUCT INFORMATION RotaTeq (rotavirus vaccine, live, oral, pentavalent, MSD) NAME OF THE MEDICINE Rotavirus vaccine live oral pentavalent DESCRIPTION RotaTeq is a live, oral pentavalent reassortant vaccine
More informationNovel H1N1 Influenza. It s the flu after all! William Muth M.D. Samaritan Health Services 9 November 2009
Novel H1N1 Influenza It s the flu after all! William Muth M.D. Samaritan Health Services 9 November 2009 Influenza A Primer.. What is the flu? How do you get it? What s a virus anyhow? Can the flu be prevented,
More informationInfluenza and the Flu Shot Facts for Health Care Workers
Influenza and the Flu Shot Facts for Health Care Workers 2014-2015 Presentation to (group name) Your Name Your Title Date Influenza Facts o Highly contagious and common respiratory illness caused by influenza
More informationWYANDOT COUNTY 2018 COMMUNICABLE DISEASE REPORT. The communicable disease summary of reportable infectious diseases for January 2018 December 2018.
WYANDOT COUNTY 2018 COMMUNICABLE DISEASE REPORT The communicable disease summary of reportable infectious diseases for January 2018 December 2018. TABLE OF CONTENTS Annual Communicable Diseases... 3 Communicable
More informationVIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks
INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry
More informationINFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE
INFLUENZA VIRUS INFLUENZA VIRUS CDC WEBSITE http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm 1 THE IMPACT OF INFLUENZA Deaths: PANDEMICS 1918-19 S p a n is h flu 5 0 0,0 0 0 U S 2 0,0 0 0,0 0 0 w o rld
More informationInfluenza A (H1N1)pdm09 in Minnesota Epidemiology
Influenza A (H1N1)pdm09 in Minnesota Epidemiology Infectious Disease Epidemiology, Prevention and Control Division PO Box 64975 St. Paul, MN 55164-0975 Number of Influenza Hospitalizations by Influenza
More informationBangladesh: How to move from data to implementation. K. Zaman, MBBS, PhD Senior Scientist and Epidemiologist icddr,b
Bangladesh: How to move from data to implementation K. Zaman, MBBS, PhD Senior Scientist and Epidemiologist icddr,b Rotavirus in Bangladesh Estimated 2.4 million cases of rotavirus diarrhoea annually in
More informationUpdates on Rotasiil development
Updates on Rotasiil development 13 th International Rotavirus Symposium Minsk, Belarus 30 August 2018 Dr Sajjad Desai MD Serum Institute of India Pvt Limited, Pune Rotasiil Bovine-human reassortant strains
More informationGastrointestinal Infections in Northern Ireland
Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 213 Gastrointestinal Infections in Northern Ireland Annual Surveillance Report 213 Contents Key Points...1 Introduction...2 Food
More informationMicrobial Etiology of Acute Gastroenteritis in Hospitalized Children in Taiwan
ORIGINAL ARTICLE Microbial Etiology of Acute Gastroenteritis in Hospitalized Children in Taiwan Shan-Ming Chen, 1,2 Yen-Hsuan Ni, 1 * Huey-Ling Chen, 1 Mei-Hwei Chang 1 Background/Purpose: Viral infections
More informationSensorlux Norovirus surveillance in Luxembourg
2 ème Colloque sur la sécurité de la chaîne alimentaire au Luxembourg et dans l'union européenne Sensorlux Norovirus surveillance in Luxembourg Jacques Kremer, PhD Institute of Immunology LNS-CRP-Santé,
More informationRotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) Oral Solution Initial U.S. Approval: 2006
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RotaTeq safely and effectively. See full prescribing information for RotaTeq. RotaTeq (Rotavirus
More informationSeasonal Influenza in Alberta 2010/2011 Summary Report
Seasonal Influenza in Alberta 21/211 Summary Report Government of Alberta October 211 ISSN 1927-4114, Surveillance and Assessment Branch Send inquiries to: Health.Surveillance@gov.ab.ca Executive Summary
More informationPRODUCT MONOGRAPH. RotaTeq. rotavirus vaccine, live, oral, pentavalent. 2 ml Solution
PRODUCT MONOGRAPH RotaTeq rotavirus vaccine, live, oral, pentavalent 2 ml Solution Live, Oral Pentavalent Vaccine Against Rotavirus Gastroenteritis MERCK CANADA INC. 16750 route Transcanadienne Kirkland
More informationRunning head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1
Running head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1 Electron micrograph of H1N1 Virus (CDC, 2009) Influenza Virus Season Preparedness and Response Patricia Bolivar Walden University Epidemiology
More informationRotavirus is the most common cause of severe gastroenteritis in children throughout the
Focused Issue of This Month Su Eun Park, MD Department of Childhood and Adolescent Medicine, Pusan National University College of Medicine E mail : psepse@naver.com J Korean Med Assoc 2008; 51(2): 137-143
More informationRSV Surveillance in the U.S.
RSV Surveillance in the U.S. Susan I. Gerber, MD Respiratory Virus Program Division of Viral Diseases National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention
More informationA NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT. Introducing the Gates Medical Research Institute
A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT Introducing the Gates Medical Research Institute MY JOURNEY A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT Introducing the Gates Medical Research
More informationHospital Norovirus Outbreak Reporting
Second Report of the Health Protection Agency. Hospital Norovirus Outbreak Reporting Summary findings In January 2009 the HPA in conjunction with the Infection Prevention Society launched a voluntary National
More informationRespiratory System Virology
Respiratory System Virology Common Cold: Rhinitis. A benign self limited syndrome caused by several families of viruses. The most frequent acute illness in industrialized world. Mild URT illness involving:
More informationPandemic Influenza: Global and Philippine Situation
Pandemic Influenza: Global and Philippine Situation Beatriz Puzon-Quiambao, MD, FPPS, FPIDSP Research Institute for Tropical Medicine 17 th Annual PIDSP Convention, February 3-4, 2010 Chronology of Events
More informationInfluenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong
Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Classification & Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H 1-16), neuraminidase (N1-9)
More information1/31/2013 DISEASE BASICS. Influenza; Implications for Public Health Professionals. Influenza: An Age-Old Disease, A Disease for All Ages
Influenza; Implications for Public Health Professionals Phillip L. Barkley, M.D. Director of Student Health University of Florida DISEASE BASICS Influenza: An Age-Old Disease, A Disease for All Ages Epidemics
More informationRotaTeq PRODUCT MONOGRAPH. rotavirus vaccine, live, oral, pentavalent. 2 ml Solution. Live, Oral Pentavalent Vaccine Against Rotavirus Gastroenteritis
PRODUCT MONOGRAPH RotaTeq rotavirus vaccine, live, oral, pentavalent 2 ml Solution Live, Oral Pentavalent Vaccine Against Rotavirus Gastroenteritis MERCK CANADA INC. 16750 route Transcanadienne Kirkland,
More informationPUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA
INFLUENZA DEFINITION Influenza is an acute highly infectious viral disease characterized by fever, general and respiratory tract catarrhal manifestations. Influenza has 3 Types Seasonal Influenza Avian
More information